New Study Suggests Activity of Propranolol in Hypotrichosis-Lymphedema-Telangiectasia Patients
https://pixabay.com/en/tablets-pharmacy-medications-cure-2248375/

New Study Suggests Activity of Propranolol in Hypotrichosis-Lymphedema-Telangiectasia Patients

According to a publication from ScienceDaily, a new study of propranolol suggests explanations for its ability to shrink certain benign tumors in infants and relieve symptoms of hypotrichosis-lymphedema-telangiectasia syndrome. About…

Continue Reading New Study Suggests Activity of Propranolol in Hypotrichosis-Lymphedema-Telangiectasia Patients

Researchers Find Success in Precision Cutting as a Exciting New Treatment for Inflammatory Bowel Disease

As reported in EurekAlert, an exciting new treatment method has entered the conversation to treat inflammatory bowel disease (IBD). Researchers have successfuly used mice population to show that precision cutting…

Continue Reading Researchers Find Success in Precision Cutting as a Exciting New Treatment for Inflammatory Bowel Disease
Neurogene Sponsors Invitae’s No-Charge Genetic Testing Program for Suspected Lysosomal Disease Patients
qimono / Pixabay

Neurogene Sponsors Invitae’s No-Charge Genetic Testing Program for Suspected Lysosomal Disease Patients

According to a press release from American biotechnology company Neurogene, the Company has kicked off a sponsorship of Invitae Corporation's "Detect Lysosomal Storage Diseases" program, which will offer genetic testing…

Continue Reading Neurogene Sponsors Invitae’s No-Charge Genetic Testing Program for Suspected Lysosomal Disease Patients

Bladder Cancer Drug That Received Accelerated Approval Shows Even Stronger Findings in Later Study

According to a publication from Medscape, the first ever drug targeted for bladder cancer has shown even more impressive results in post-approval study. Erdafitinib was approved on an accelerated basis…

Continue Reading Bladder Cancer Drug That Received Accelerated Approval Shows Even Stronger Findings in Later Study
Estela Lugo of the Hereditary Neuropathy Foundation Seeks to Raise Charcot-Marie-Tooth Disease Awareness
harpenz / Pixabay

Estela Lugo of the Hereditary Neuropathy Foundation Seeks to Raise Charcot-Marie-Tooth Disease Awareness

According to a story from Charcot-Marie-Tooth Disease News, Charcot-Marie-Tooth disease is actually somewhat common in the US compared to other rare diseases. In fact, it is estimated that around 150,000…

Continue Reading Estela Lugo of the Hereditary Neuropathy Foundation Seeks to Raise Charcot-Marie-Tooth Disease Awareness
Immunocore and Pulse Infoframe Lend Support to International Uveal Melanoma Patient Registry
Source: Pixabay

Immunocore and Pulse Infoframe Lend Support to International Uveal Melanoma Patient Registry

According to a press release from British biotechnology company Immunocore, the Company has partnered with Pulse Infoframe (a Canadian data analytics company) to support the development of an international database…

Continue Reading Immunocore and Pulse Infoframe Lend Support to International Uveal Melanoma Patient Registry
Researchers Discover “Testicular Cancer-Associated Paraneoplastic Encephalitis,” an Autoimmune Disease
derneuemann / Pixabay

Researchers Discover “Testicular Cancer-Associated Paraneoplastic Encephalitis,” an Autoimmune Disease

According to a story from Cancer Health, a team of scientists affiliated with Mayo Clinic, UC San Francisco, and the Chan Zuckerburg Biohub have discovered a new rare, autoimmune disease…

Continue Reading Researchers Discover “Testicular Cancer-Associated Paraneoplastic Encephalitis,” an Autoimmune Disease
Hereditary Angioedema Drug Shows Safety and Efficacy in Pediatric Patients, Study Shows
cherylholt / Pixabay

Hereditary Angioedema Drug Shows Safety and Efficacy in Pediatric Patients, Study Shows

According to a story from Angioedema News, a recent clinical trial has demonstrated that the drug conestat alfa (marketed as Ruconest) was able to successfully treat 96 percent of acute…

Continue Reading Hereditary Angioedema Drug Shows Safety and Efficacy in Pediatric Patients, Study Shows